Stay updated with breaking news from Valuating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Neumifil is a novel broad-spectrum anti-viral product that was shown to be well-tolerated with no safety signals at all doses tested - Pneumagen plans to conduct a Phase 2 Influenza challenge
WASHINGTON (dpa-AFX) - Biopharmaceutical company AbbVie Inc. (ABBV) announced on Wednesday positive topline results from U-ENDURE, its Phase 3 maintenance study evaluating upadacitinib in adult
Use of GeNeuro's temelimab as part of the first personalized medicine approach in severe post-COVID neuropsychiatric syndromes Biomarker-based study to detect the presence of the pathogenic
Revenue of $776 million in the First Quarter, up 7% Year-over-YearCore Revenue Grew 9% to $735 millionQuarterly Cash Flow From Operating Activities of $65 million SAN ANTONIO, May 10, 2022 (GLOBE NEWSWIRE)
President Joe Biden on Tuesday said that he is discussing the future of China tariffs imposed by the Trump administration cautioning that no decision has been made.